Masimo (MASI) Share-based Compensation Growth (3y) (2012 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.36% |
| 10 | Masimo | 9.32 Bn | 9.20 Bn | 250.80 Mn | 6.83% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 6.83% |
| Jan 3, 2026 | 14.05% |
| Sep 27, 2025 | -11.68% |
| Jun 28, 2025 | -21.09% |
| Mar 29, 2025 | -5.84% |
| Dec 28, 2024 | 8.37% |
| Mar 30, 2024 | -11.87% |
| Sep 30, 2023 | -27.90% |
| Jul 1, 2023 | -38.42% |
| Apr 1, 2023 | -13.48% |
| Dec 31, 2022 | -14.47% |
| Oct 1, 2022 | 7.54% |
| Jul 2, 2022 | 14.67% |
| Apr 2, 2022 | 14.21% |
| Jan 1, 2022 | 2.55% |
| Apr 3, 2021 | 33.58% |
| Sep 26, 2020 | 33.12% |
| Jun 27, 2020 | 59.45% |
| Mar 28, 2020 | 57.43% |
| Dec 28, 2019 | 50.56% |
| Sep 28, 2019 | 45.99% |
| Jun 29, 2019 | 53.42% |
| Mar 30, 2019 | 34.21% |
| Dec 29, 2018 | 36.43% |
| Mar 31, 2018 | 22.59% |
| Sep 30, 2017 | 25.16% |
| Jul 1, 2017 | 7.66% |
| Apr 1, 2017 | 3.56% |
| Dec 31, 2016 | 1.92% |
| Oct 1, 2016 | 10.30% |
| Jul 2, 2016 | 1.93% |
| Apr 2, 2016 | -3.92% |
| Jan 2, 2016 | -0.25% |
| Apr 4, 2015 | -8.68% |
| Sep 27, 2014 | -0.31% |
| Jun 28, 2014 | -14.01% |
| Mar 29, 2014 | -8.84% |
| Dec 28, 2013 | -15.51% |
| Sep 28, 2013 | 0.40% |
| Jun 29, 2013 | -5.01% |
| Mar 30, 2013 | 6.59% |
| Sep 29, 2012 | 9.61% |